Most GLP-1 medications like semaglutide (Ozempic, Wegovy) and liraglutide are administered by subcutaneous injection, bypassing the digestive system entirely
This is a medical therapy, just like for hypertension or diabetes. This class of medications has proven to be broadly effective at helping people with obesity lose weight and in reducing heart attacks and stroke among people with heart disease
Industry activity suggests rapid development in this area [14], but clinical adoption will depend on functional benefits, safety, cost-effectiveness and regulatory guidance
Clinical trials have found that the greatest improvement in haemoglobin A1c occurs within the first 24 weeks of treatment, after which levels stabilise
It may be particularly suitable for researchers who have had difficulty tolerating other weight loss peptides or those who are using retatrutide for metabolic benefits beyond weight loss
Hyperinsulinemia associated depression